ARKG vs VGK
ARK Genomic Revolution ETF vs Vanguard FTSE Europe ETF
ARKG$43.00
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
VGK$88.41
Vanguard FTSE Europe ETF
European developed-market equities.
Expense: 0.06%Yield: 2.90%
Quick take
- • VGK has the lower expense ratio at 0.06% vs 0.75% for ARKG.
- • VGK pays a higher dividend yield (2.90%).
Side-by-side metrics
| Metric | ARKG | VGK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.06% |
Dividend yield Trailing 12-month yield. | 0.00% | 2.90% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $37.86B |
YTD return | 44.53% | 7.41% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.90 |
P/E ratio | — | 17.80 |
Last price | $43.00 | $88.41 |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
VGK top holdings
Top holdings · VGK
| ASML.AS | ASML Holding NV | 3.97% |
| HSBA.L | HSBC Holdings PLC | 2.04% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.87% |
| NOVN.SW | Novartis AG Registered Shares | 1.83% |
| AZN.L | AstraZeneca PLC | 1.76% |
| NESN.SW | Nestle SA | 1.65% |
| SHEL.L | Shell PLC | 1.52% |
| SIE.DE | Siemens AG | 1.46% |
| SAP.DE | SAP SE | 1.18% |
| SAN.MC | Banco Santander SA | 1.16% |
Sector breakdown · VGK
Real Estate1.6%
Consumer Cyclical7.1%
Basic Materials5.6%
Consumer Defensive7.7%
Technology9.4%
Communication Services3.1%
Financial Services23.4%
Utilities4.4%
Industrials20.3%
Energy5.0%
Healthcare12.4%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VGK
VGK (Vanguard FTSE Europe ETF) is European developed-market equities. Managed by Vanguard, the fund carries $37.9B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.90%. Its largest holding is ASML Holding NV (ASML.AS), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.